RPG Life Sciences Reports Strong Q2 FY26 Results; CFO Vishal Shah Resigns, Effective Oct 23
RPG Life Sciences reported strong Q2 FY26 results with ₹3,685 lakhs profit. CFO Vishal Shah resigned, effective Oct 23, 2025. Fire incident loss partially recovered by insurance.
The positive financial performance for the quarter and half-year is a significant factor. The resignation of a Key Managerial Personnel like the CFO could lead to some uncertainty, but the company's proactive search for a replacement and the management of the fire incident's financial impact through insurance suggest a controlled situation. The combination of strong results and a key personnel change warrants a medium impact.
The company reported strong financial results for both the quarter and half-year, with significant profit growth. While the CFO's resignation introduces a change in leadership, the company is actively seeking a replacement. The financial impact of the past fire incident is being mitigated by insurance recoveries, with the company confident of recovering the remaining loss, contributing to an overall positive outlook.
* RPG Life Sciences Limited's Board of Directors met on October 17, 2025, to approve the unaudited financial results for the quarter and half-year ended September 30, 2025. * For the quarter ended September 30, 2025: * Revenue from Operations stood at ₹18,168 lakhs. * Profit for the period was ₹3,685 lakhs. * Basic Earnings per Share (EPS) was ₹22.28. * For the six months ended September 30, 2025: * Revenue from Operations was ₹35,060 lakhs. * Profit for the period amounted to ₹6,314 lakhs. * Basic Earnings per Share (EPS) was ₹38.18. * Mr. Vishal Shah has resigned from his position as Chief Financial Officer and Key Managerial Personnel due to personal reasons, effective from the close of business hours on October 23, 2025. * The company is actively seeking a suitable candidate to fill the vacant CFO position and will inform the Stock Exchanges once the appointment is finalized. * Regarding the fire incident on January 2, 2025, a loss of ₹2,561 lakhs has been recognized. Interim insurance payments totaling ₹2,050 lakhs have been received, resulting in a net loss of ₹511 lakhs as of September 30, 2025. The company is confident of recovering the remaining loss from the insurance company.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.